Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
企業コードPLRZ
会社名Polyrizon Ltd
上場日Oct 29, 2024
最高経営責任者「CEO」Mr. Tomer Izraeli
従業員数1
証券種類Ordinary Share
決算期末Oct 29
本社所在地HaTidhar St. 5
都市RA'ANANA
証券取引所NASDAQ Capital Market Consolidated
国Israel
郵便番号- -
電話番号97293740120
ウェブサイトhttps://polyrizon-biotech.com/
企業コードPLRZ
上場日Oct 29, 2024
最高経営責任者「CEO」Mr. Tomer Izraeli
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし